Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN001173 | 54.0478 | 2.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 55.0430 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 56.0620 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 56.0633 | 19.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 57.0578 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 57.0584 | 1.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 58.0421 | 14.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 58.0424 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 69.0571 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 70.0806 | 19.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 71.0733 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 71.0744 | 0.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 73.0895 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 73.0895 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 73.0896 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 75.0385 | 5.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 76.0026 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 78.0122 | 0.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 82.0787 | 2.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 83.0352 | 1.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 83.9528 | 0.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 85.0888 | 1.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 87.0318 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 89.0481 | 3.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 90.0443 | 20.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 92.0474 | 5.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 96.0677 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 98.0368 | 2.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 98.0372 | 0.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 98.0728 | 1.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 99.1046 | 3.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 99.1052 | 2.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 102.0153 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 103.0448 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 103.0993 | 21.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 103.0995 | 21.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 103.0995 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 103.0995 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 103.0996 | 22.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 104.0614 | 16.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 106.0100 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 106.0622 | 9.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 110.1089 | 21.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 111.0690 | 2.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 113.0300 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 113.0841 | 4.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 114.1041 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 115.0980 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 115.1001 | 1.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 118.0782 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 119.0407 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 120.0434 | 5.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 124.9793 | 0.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 126.0316 | 3.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 129.0476 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 129.1520 | 4.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 130.0082 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 131.0682 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 131.9775 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 132.0229 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 132.0697 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 134.0724 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 135.0567 | 4.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 135.0647 | 4.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 135.0663 | 1.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 135.9926 | 0.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 136.0388 | 2.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 137.0835 | 2.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 138.0539 | 5.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 138.1043 | 6.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 143.0902 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 145.1100 | 3.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 146.0496 | 4.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 147.0863 | 0.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 148.0151 | 19.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 148.0156 | 20.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 148.0157 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 148.0168 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 148.0183 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 148.0523 | 17.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 148.0524 | 18.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 148.0879 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 150.1041 | 10.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 151.0242 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 151.0263 | 0.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 152.0454 | 3.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 154.9664 | 1.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 156.0764 | 3.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 156.0764 | 3.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 157.1083 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 157.1085 | 2.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 157.1463 | 15.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 158.0844 | 3.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 159.0338 | 2.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 159.0354 | 9.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 159.0354 | 10.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 159.0355 | 8.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 159.0356 | 7.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 159.0356 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 159.0357 | 8.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 159.0357 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 159.0881 | 3.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 159.1253 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 159.1260 | 6.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 159.1263 | 0.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 160.0781 | 3.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 161.0325 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 161.0336 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 161.0363 | 2.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 162.0375 | 4.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 162.0678 | 20.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 162.1256 | 9.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 164.0453 | 1.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 166.0059 | 0.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 166.0297 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 166.0611 | 17.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 167.0562 | 2.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 169.0739 | 2.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 169.1093 | 7.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 170.0512 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 170.1410 | 10.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 171.0308 | 1.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 171.0422 | 5.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 171.0941 | 22.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 171.1617 | 17.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 172.0713 | 2.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 172.1461 | 14.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 173.0508 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 174.0259 | 4.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 174.0265 | 4.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 174.1405 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 175.0472 | 0.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 175.0634 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 175.0637 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 175.0641 | 9.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 175.0848 | 0.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 177.9389 | 0.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 178.0081 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 179.0054 | 1.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 179.1022 | 5.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 179.1285 | 15.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 180.0218 | 1.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 181.0716 | 1.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 181.0718 | 3.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 181.9422 | 2.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 181.9422 | 2.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 182.0906 | 4.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 183.0887 | 2.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 184.1077 | 9.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 185.1037 | 2.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 185.1762 | 18.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 185.2134 | 17.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 186.0461 | 1.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 186.0894 | 4.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 186.0994 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 187.0255 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 187.1214 | 7.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 188.0128 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 188.0605 | 3.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 188.0617 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 190.0967 | 10.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 190.0970 | 10.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 190.1568 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 190.1570 | 14.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 191.0484 | 2.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 191.0949 | 6.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 191.9542 | 0.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 192.0903 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 192.1508 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 193.0820 | 5.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 193.1432 | 17.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 194.0942 | 17.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 194.1130 | 21.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 194.1155 | 3.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 195.0533 | 10.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 195.0919 | 0.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 195.0933 | 0.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 196.1081 | 6.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 196.1204 | 4.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 196.1210 | 3.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 197.0289 | 0.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 197.0454 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 197.0801 | 1.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 197.0877 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 197.1400 | 1.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 197.1418 | 12.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 197.1776 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 198.0508 | 2.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 198.1616 | 21.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 198.1625 | 17.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 199.1572 | 22.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 199.1574 | 12.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 199.1574 | 22.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 199.1930 | 20.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 200.0666 | 2.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 200.1515 | 7.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 201.0845 | 5.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 201.1004 | 3.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 203.1152 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 203.1160 | 8.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 203.1504 | 4.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 203.9752 | 2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 203.9763 | 19.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 204.0135 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 204.0782 | 20.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 205.0745 | 7.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | L-TRYPTOPHAN-15N2 [ISTD] (M+H)+ | 206.0845 | 3.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001173 | 206.0948 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 207.0558 | 0.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 207.0881 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 207.0895 | 6.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 208.0439 | 5.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 209.0072 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 209.0370 | 4.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 209.0378 | 4.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 209.0421 | 1.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 209.1077 | 1.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 210.0513 | 4.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 210.1357 | 7.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 210.1615 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 210.9932 | 2.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 211.0878 | 2.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 211.1117 | 6.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 211.2290 | 18.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 211.2291 | 19.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 212.1393 | 14.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 212.1393 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 213.2452 | 17.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 214.0213 | 1.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 214.0892 | 3.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 214.1183 | 7.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 215.0636 | 5.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 215.1120 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 215.1523 | 12.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 215.1885 | 14.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 216.0585 | 12.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 216.0972 | 3.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 216.9825 | 8.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 217.0094 | 4.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 217.1288 | 4.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 218.0186 | 0.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 219.0400 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 220.1174 | 0.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 220.1238 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 220.1762 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 221.0216 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 221.1388 | 12.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 221.1400 | 22.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 221.1740 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 221.1754 | 20.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 222.1233 | 10.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 222.1234 | 10.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 222.1345 | 7.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 223.1543 | 12.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 224.0263 | 0.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 224.1047 | 12.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 225.0092 | 4.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 225.0092 | 4.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 225.0984 | 8.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 225.1014 | 5.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 225.1341 | 7.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 225.1720 | 22.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 225.1733 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 226.0955 | 2.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 226.9896 | 19.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 227.0560 | 7.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 227.1883 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 227.1886 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 227.1889 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 227.2216 | 21.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 227.2607 | 17.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 228.0656 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 228.0902 | 3.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 228.1059 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 228.1124 | 0.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 228.1128 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 228.1336 | 11.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 228.1338 | 9.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 228.1444 | 4.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 228.1477 | 2.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 228.1833 | 11.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 228.9644 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 229.0355 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 229.0373 | 0.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 229.1306 | 1.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 229.1671 | 4.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 229.1675 | 4.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 229.1678 | 14.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 229.1739 | 1.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 229.2404 | 17.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 229.2405 | 17.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 229.9933 | 1.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 230.0153 | 4.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 230.1276 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 230.1629 | 4.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 230.9627 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 231.0361 | 5.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 231.0561 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 231.1833 | 15.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 232.0712 | 10.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 232.1001 | 1.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 232.9763 | 1.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 233.1233 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 233.1258 | 1.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 234.0879 | 10.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 234.1612 | 19.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 234.1800 | 5.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 235.1554 | 14.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 236.0457 | 2.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 236.1485 | 9.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 237.1047 | 18.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 237.1345 | 12.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 237.1705 | 14.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 238.0986 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 238.1350 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 238.1372 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 238.1373 | 4.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 238.1540 | 17.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 238.1543 | 17.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 238.2048 | 16.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 238.2295 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 239.1159 | 6.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 239.1881 | 15.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 239.1881 | 17.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 239.2251 | 13.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 240.0247 | 8.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 240.0620 | 8.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 240.0968 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 240.1444 | 1.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 240.1502 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 241.2031 | 16.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 241.2038 | 22.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 241.2039 | 16.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 241.2044 | 17.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 241.2044 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 241.2769 | 11.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 241.2770 | 18.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 241.2770 | 18.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 242.0466 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 242.0469 | 4.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 242.0828 | 18.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 242.1126 | 4.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 242.1981 | 13.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 242.2000 | 8.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 243.1473 | 4.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 243.1830 | 13.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 243.1837 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 244.0222 | 7.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 244.0400 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 244.0737 | 14.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 244.1075 | 17.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 244.1707 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 244.1743 | 0.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 245.0009 | 19.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 245.0031 | 19.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 245.1129 | 0.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 245.1199 | 18.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 245.1448 | 16.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 246.0870 | 2.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 246.1158 | 6.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 246.1621 | 11.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 246.1679 | 15.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 246.9978 | 8.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 247.1423 | 1.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 248.1469 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 248.1732 | 19.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 248.1733 | 18.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 248.9974 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 249.0824 | 5.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 249.0845 | 5.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 249.1174 | 1.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 249.1262 | 2.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 249.1708 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 249.1945 | 2.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 250.0651 | 4.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 250.0652 | 4.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 250.0698 | 2.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 250.0967 | 9.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 250.1530 | 0.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 250.1653 | 11.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 251.0968 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 251.1206 | 19.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 251.1220 | 5.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 251.1244 | 5.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 251.1358 | 1.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 251.1499 | 14.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 251.1510 | 14.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 251.1995 | 8.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 253.0761 | 18.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 253.1294 | 2.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 253.1418 | 1.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 253.1652 | 9.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 253.1656 | 15.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 253.1657 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 253.2037 | 18.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 254.2251 | 21.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 255.1142 | 5.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 255.1371 | 19.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 255.1757 | 16.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 255.1836 | 15.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 255.2194 | 20.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 255.2196 | 18.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 255.2561 | 22.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 255.9502 | 0.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 256.0281 | 4.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 256.0298 | 4.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 256.1106 | 16.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 256.1776 | 6.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 256.2153 | 15.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 257.0603 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 257.0735 | 4.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 257.1261 | 1.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 257.1991 | 17.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 257.1996 | 17.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 257.2352 | 17.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 257.2719 | 19.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 257.2723 | 19.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 258.0338 | 4.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 258.0843 | 5.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 258.1135 | 2.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 258.1262 | 17.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 258.1580 | 3.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 258.1810 | 19.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 259.1785 | 6.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 260.0792 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 260.1031 | 14.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 260.1032 | 14.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 260.1210 | 5.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 260.1277 | 4.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 260.1475 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 260.1716 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 260.1846 | 16.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | HEXANOYLCARNITINE (*) M+ | 260.1862 | 7.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001173 | 261.1178 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 261.1205 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 261.1221 | 6.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 261.1227 | 2.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 261.1593 | 2.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 261.1698 | 16.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 261.1705 | 17.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 262.0676 | 4.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 262.0779 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 262.1129 | 10.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 262.1202 | 5.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 262.1395 | 0.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 262.1571 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 262.1648 | 12.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 263.1206 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 263.1504 | 12.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 263.1855 | 16.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 263.1865 | 17.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 263.2459 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 264.0416 | 2.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 264.1155 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 264.1448 | 9.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 264.1813 | 13.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 264.1819 | 8.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 264.9690 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 265.1308 | 4.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 265.1361 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 265.1658 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 265.1660 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 265.1988 | 17.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 265.2148 | 10.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 265.2153 | 9.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 266.0357 | 4.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 266.0358 | 4.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 266.1177 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 266.1187 | 3.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 266.1310 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 266.1362 | 1.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 266.1659 | 20.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 267.1454 | 4.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 267.1810 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 267.1815 | 14.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 268.0175 | 20.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 268.0213 | 19.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 268.1168 | 3.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 268.1317 | 15.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 268.1529 | 1.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 268.2012 | 21.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 269.9934 | 1.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 270.2296 | 12.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 270.9733 | 0.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 271.0789 | 6.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 271.1786 | 6.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 271.2148 | 18.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 271.2885 | 17.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 272.0519 | 2.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 272.0620 | 5.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 272.1040 | 16.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 272.1399 | 5.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 272.1595 | 12.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 272.2454 | 12.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 273.0307 | 3.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 273.0822 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 273.0822 | 1.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 273.1006 | 7.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 273.1941 | 9.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 273.1944 | 8.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 273.2665 | 17.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 273.2669 | 17.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 274.0044 | 4.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 274.1098 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 274.1332 | 6.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 275.1873 | 17.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 276.0532 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 276.0883 | 5.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 276.1338 | 14.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 276.1736 | 19.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 276.2075 | 22.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 277.1521 | 1.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 277.2017 | 18.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 277.2379 | 22.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 277.2401 | 20.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 277.2409 | 22.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 278.0323 | 10.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 278.1511 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 278.1520 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 278.1976 | 15.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 279.1124 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 279.1308 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 279.1328 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 279.1505 | 16.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 279.1517 | 21.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 279.1810 | 17.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 279.1812 | 17.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 279.1822 | 15.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 279.2315 | 11.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 279.2388 | 11.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 279.2553 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 280.0876 | 16.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 280.1005 | 5.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 280.1072 | 9.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 280.1314 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 280.1621 | 19.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 281.1246 | 2.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 281.1312 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 281.1967 | 17.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 281.1974 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 282.0356 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 282.0620 | 0.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 282.1261 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 282.1265 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 282.1568 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 282.1712 | 5.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 282.2195 | 21.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 283.1466 | 20.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 283.1774 | 14.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 283.2144 | 18.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 283.2873 | 22.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 283.3237 | 21.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 284.0391 | 2.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 284.0597 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 284.0960 | 18.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 284.1211 | 6.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 284.1383 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 284.1415 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 284.1417 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 284.1713 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 284.2104 | 11.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 284.2392 | 22.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 284.2459 | 11.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 284.2460 | 17.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 285.0923 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 285.2660 | 17.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 286.0270 | 2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 286.0312 | 19.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 286.1175 | 1.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 286.2256 | 11.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 286.2351 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 286.2615 | 14.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 286.9744 | 1.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 287.1486 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 287.1505 | 15.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 287.2461 | 20.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 287.2468 | 17.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 287.2813 | 18.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 287.2820 | 16.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 287.2823 | 19.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 288.0288 | 5.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 288.0425 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 288.1199 | 5.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 288.1239 | 5.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 288.1474 | 20.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 288.2411 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 288.2419 | 12.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 288.2774 | 14.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 289.0962 | 4.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 289.1074 | 7.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 289.2619 | 17.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 290.0375 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 290.0829 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 290.1135 | 15.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 290.1270 | 11.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 290.1843 | 3.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 290.1882 | 19.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 291.1098 | 2.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 292.0868 | 5.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 292.2001 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 292.2011 | 21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 293.0928 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 293.1289 | 11.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 293.1293 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 293.1482 | 1.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 293.1970 | 18.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 293.2076 | 10.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 293.2325 | 20.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 293.2705 | 22.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 294.0922 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 294.1051 | 18.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 294.1094 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 294.1238 | 4.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 294.1687 | 15.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 295.0581 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 295.1292 | 4.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 295.1767 | 15.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 295.2126 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 295.2404 | 17.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 296.0495 | 1.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 296.0495 | 1.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 296.1069 | 18.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 296.1417 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 296.1579 | 21.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 296.2087 | 14.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 296.2324 | 22.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 296.2471 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 296.2713 | 23.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 297.0746 | 2.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 297.1033 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 297.1203 | 2.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 297.1933 | 15.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 297.2283 | 15.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 297.2630 | 21.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 297.2644 | 19.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 298.0358 | 0.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 298.0748 | 4.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 298.0849 | 3.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 298.1051 | 12.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 298.1571 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 299.0924 | 4.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 299.0963 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 299.2778 | 21.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 299.3182 | 19.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 299.9779 | 0.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 300.0325 | 0.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 300.1048 | 5.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 300.1323 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 300.1338 | 20.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 300.1342 | 20.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 300.1361 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 300.1710 | 19.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 300.2779 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 301.0619 | 20.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 301.1126 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 301.2383 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 301.2619 | 17.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 301.2681 | 11.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 301.2694 | 17.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 302.1400 | 4.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 302.1525 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 302.1561 | 2.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 302.1592 | 3.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 302.1666 | 10.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 302.2556 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 302.2560 | 14.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 303.0956 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 303.2932 | 18.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 304.0152 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 304.0926 | 1.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 304.1266 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 304.1266 | 1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 304.1554 | 5.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 304.1580 | 6.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 304.2418 | 22.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 304.2731 | 12.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 305.0731 | 9.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 305.1969 | 18.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 305.2682 | 22.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 306.0098 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 306.0245 | 2.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 306.0361 | 8.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 306.0874 | 19.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 306.0934 | 6.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 306.1055 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 306.1625 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 306.2277 | 17.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 307.0843 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 307.1841 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 307.2098 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 307.2099 | 0.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 307.2145 | 16.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 307.2473 | 20.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 307.2613 | 14.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 307.2871 | 21.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 307.2874 | 21.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 307.2875 | 22.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 308.1202 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 308.1205 | 9.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 308.1241 | 15.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 308.1244 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 308.1536 | 17.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 308.1967 | 21.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 308.2074 | 14.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 309.0890 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 309.1210 | 2.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 309.1924 | 13.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 309.2027 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 309.2275 | 20.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 309.2278 | 18.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 309.3036 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 310.1196 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 310.1215 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 310.1221 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 310.1788 | 17.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 310.1812 | 21.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 310.1987 | 21.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 310.2554 | 17.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 310.2598 | 10.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 311.1017 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 311.1414 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 311.1879 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 311.2074 | 15.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 311.2927 | 16.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 311.3185 | 23.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 312.0043 | 1.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 312.0987 | 12.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 312.1048 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 312.1371 | 20.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 312.2265 | 21.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 312.2664 | 22.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 312.2668 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 312.2764 | 17.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 313.0770 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 313.0966 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 314.0213 | 8.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 314.0559 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 314.1163 | 18.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 314.1509 | 18.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 314.1667 | 21.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 314.1856 | 21.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 314.1928 | 5.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 314.2575 | 12.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 315.0957 | 2.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 315.1086 | 11.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 315.1091 | 11.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 315.1300 | 1.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 315.1301 | 1.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 315.2071 | 14.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 315.2176 | 20.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 315.2177 | 20.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 315.2215 | 19.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 315.2890 | 13.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 316.1036 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 316.1322 | 6.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 316.1665 | 17.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 316.1670 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 316.1830 | 12.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 316.1998 | 2.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 316.2730 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 317.1075 | 1.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 317.1977 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 317.2331 | 21.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 317.2332 | 20.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 317.2597 | 17.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 317.2922 | 17.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 317.2929 | 16.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 317.3072 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 318.0319 | 1.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 318.1323 | 3.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 318.1885 | 22.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 318.1920 | 14.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 318.2861 | 22.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 318.2866 | 14.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 318.2873 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 319.0367 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 319.1756 | 15.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 319.1762 | 15.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 320.0618 | 4.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 320.1240 | 9.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 320.1242 | 10.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 320.1375 | 3.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 320.1782 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 320.2046 | 22.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 321.0545 | 10.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 321.0701 | 0.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 321.0701 | 1.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 321.0941 | 10.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 321.1390 | 5.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 321.1580 | 8.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 321.1692 | 4.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 321.2292 | 21.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 321.2636 | 21.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 321.3027 | 22.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 322.0870 | 5.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 322.0882 | 6.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 322.1046 | 8.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 322.1166 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 322.1549 | 3.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 322.1576 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 322.2194 | 23.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 322.2482 | 22.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 323.0939 | 0.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 323.2101 | 16.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 323.2170 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 323.2439 | 20.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 323.2806 | 21.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 323.3178 | 23.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 324.1359 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 324.1485 | 3.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 324.2629 | 22.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 324.2766 | 18.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 324.2769 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 324.2781 | 11.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 325.1367 | 2.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 325.2974 | 22.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 325.3709 | 21.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 326.0012 | 16.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 326.0713 | 19.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 326.1066 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 326.1079 | 0.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 326.1155 | 6.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 326.1404 | 6.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 326.1939 | 6.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 326.2427 | 21.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 326.3301 | 21.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 327.1019 | 11.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 327.1139 | 16.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 327.1325 | 2.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 327.2789 | 22.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 327.9981 | 16.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 328.0217 | 3.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 328.1241 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 328.1321 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 328.1322 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 328.1334 | 6.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 328.1475 | 19.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 328.2362 | 23.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 329.0658 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 329.1102 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 329.1143 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 329.1397 | 10.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 329.1442 | 4.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 329.1587 | 4.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 329.1788 | 16.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 329.2216 | 16.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 329.2700 | 22.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 329.3047 | 15.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 330.1023 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 330.1060 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 330.1238 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 330.1238 | 3.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 330.1331 | 3.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 330.1334 | 8.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 330.1472 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 330.1829 | 19.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 330.1981 | 14.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 330.2784 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 330.2870 | 17.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 330.2879 | 17.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 331.1037 | 1.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 331.2858 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 331.3245 | 20.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 331.3250 | 19.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 332.1012 | 10.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 332.1613 | 17.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 332.1974 | 14.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 332.3041 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 333.0843 | 1.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 333.1075 | 19.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 333.2880 | 17.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 333.2979 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 333.3009 | 23.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 333.3037 | 22.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 333.9705 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 334.0993 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 334.0993 | 15.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 334.0999 | 7.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 334.1185 | 20.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 334.1621 | 1.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 334.1994 | 5.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 334.2180 | 23.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 335.0620 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 335.2153 | 22.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 335.3125 | 22.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 335.3189 | 22.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 336.0979 | 18.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 336.0987 | 7.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 336.0989 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 336.0989 | 15.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 336.1487 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 336.1508 | 21.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 336.1604 | 22.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 337.2028 | 2.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 337.2263 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 337.2592 | 21.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 337.2597 | 19.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 337.3343 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 337.3346 | 22.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 337.3350 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 338.0581 | 5.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 338.1301 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 338.1488 | 2.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 338.1512 | 21.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 338.2350 | 16.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 338.2694 | 10.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 338.2925 | 13.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 339.2541 | 20.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 339.2738 | 17.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 340.0200 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 340.1358 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 340.1692 | 15.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 340.1878 | 8.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 340.2582 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 340.2593 | 22.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 340.2974 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 341.0792 | 10.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 341.1560 | 5.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 341.1930 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 341.2312 | 6.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 341.2378 | 21.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 342.0172 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 342.0410 | 1.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 342.1371 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 342.1470 | 16.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 342.1475 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 342.2881 | 11.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 342.2895 | 19.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 342.3245 | 21.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 343.0511 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 343.1247 | 5.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 343.1264 | 1.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 343.2216 | 6.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 343.2505 | 21.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 343.3424 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 344.0823 | 8.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 344.1274 | 6.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 344.1397 | 19.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 344.1617 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 344.1794 | 21.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 344.2142 | 14.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 344.3039 | 18.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 345.0397 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 345.2644 | 21.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 346.0750 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 346.1426 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 346.1768 | 18.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 346.1784 | 14.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 346.2596 | 11.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 346.3194 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 347.0667 | 1.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 347.1427 | 7.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 347.2449 | 20.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 347.2495 | 21.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 347.2621 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 347.2790 | 21.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 347.3175 | 17.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 347.3176 | 16.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 347.9798 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 347.9830 | 16.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 348.0525 | 19.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 348.1146 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 348.1270 | 19.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 348.1330 | 3.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 348.1565 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 348.1765 | 6.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 349.0572 | 1.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 349.1137 | 2.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 349.1745 | 9.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 349.1755 | 4.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 349.1767 | 7.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 349.2102 | 12.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 349.2597 | 19.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 349.2609 | 22.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 349.3332 | 21.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 349.3344 | 23.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 349.9799 | 16.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 350.0495 | 0.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 350.0923 | 20.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 350.1285 | 3.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 350.1289 | 19.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 350.1664 | 21.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 350.2260 | 22.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 350.2446 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 351.1262 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 351.1408 | 4.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 351.1558 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 351.2029 | 16.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 351.2408 | 20.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 351.2415 | 20.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 351.2419 | 19.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 351.2439 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 351.3113 | 21.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 351.3118 | 20.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 351.3137 | 22.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 351.9772 | 16.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 352.0678 | 18.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 352.0985 | 7.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 352.1098 | 10.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001173 | 352.1106 | 9.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |